Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa.
about
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosisStandard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosisStandard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosisFunction of the Pseudomonas aeruginosa NrdR Transcription Factor: Global Transcriptomic Analysis and Its Role on Ribonucleotide Reductase Gene ExpressionRespiratory pathogens adopt a chronic lifestyle in response to bile.Gene regulatory and metabolic adaptation processes of Dinoroseobacter shibae DFL12T during oxygen depletion.Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic FibrosisMimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa.In-vivo expression profiling of Pseudomonas aeruginosa infections reveals niche-specific and strain-independent transcriptional programs.Real-time determination of intracellular oxygen in bacteria using a genetically encoded FRET-based biosensorThe photophysics of LOV-based fluorescent proteins--new tools for cell biology.Regulatory and metabolic networks for the adaptation of Pseudomonas aeruginosa biofilms to urinary tract-like conditions.Pseudomonas aeruginosa: resistance to the maxChlorinated phenols control the expression of the multidrug resistance efflux pump MexAB-OprM in Pseudomonas aeruginosa by interacting with NalC.Regulation of bacterial virulence gene expression by cell envelope stress responses.Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.Targeting bacterial membrane function: an underexploited mechanism for treating persistent infectionsSmall RNAs as regulators of primary and secondary metabolism in Pseudomonas species.Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings.Proteomics of hosts and pathogens in cystic fibrosis.Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient.Luminescence materials for pH and oxygen sensing in microbial cells - structures, optical properties, and biological applications.Evaluating the Effect of Oxygen Concentrations on Antibiotic Sensitivity, Growth, and Biofilm Formation of Human Pathogens.Pandoraea pnomenusa Isolated from an Australian Patient with Cystic Fibrosis.Enzymatic characterization and in vivo function of five terminal oxidases in Pseudomonas aeruginosa.Copper efflux is induced during anaerobic amino acid limitation in Escherichia coli to protect iron-sulfur cluster enzymes and biogenesis.Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.Pseudomonas aeruginosa endophthalmitis masquerading as chronic uveitis.Regulation and Function of Versatile Aerobic and Anaerobic Respiratory Metabolism in Pseudomonas aeruginosa.Diffusive transport through a model host-biofilm system.Fine-tuned regulation of the dissimilatory nitrite reductase gene by oxygen and nitric oxide in Pseudomonas aeruginosa.Convergent Metabolic Specialization through Distinct Evolutionary Paths in Pseudomonas aeruginosa.
P2860
Q24187383-4EFD2710-04C6-4CA7-BAB4-0F5ED687C7AEQ24203005-BD74EEBE-0CA7-4647-A9B1-A7BB679E9701Q24234955-764B8261-C562-4D11-B10F-200E177C05E1Q28492885-EB12427C-AA1F-4AFF-B788-4CB50D80D2C3Q31103147-A1F18236-15B9-4910-92CE-EF7D2A6BF16EQ33676616-0C54F9EF-A662-4286-BBB1-06C5C8E25A28Q33857503-D286C385-4251-45E3-87EA-7E09C9E098C0Q33897664-F10787E9-BB0C-4C46-9959-DAC0FA40CB6FQ34023318-D83F3873-5706-4DF7-BA61-C1A061A736FDQ34206656-96A5D72F-2820-4BCD-9AD5-264B31A7CDC1Q34402598-4274FFCB-472B-4509-ACE0-D4552B85D19AQ34964566-726D9725-D348-4267-9CF6-2AD1AE1CE403Q35084559-8C3DD207-F890-43E1-B7B6-B22B3866992DQ35104234-F8A96B8E-8BE9-4FFD-9227-9FD2D8A0C290Q36147683-B1C4D255-713F-4D85-9776-6A420F344FE7Q36158775-8905F45E-BC14-4162-9110-D099F5A9E002Q36393640-0E88B8E9-991B-4A29-8352-131758003571Q37878988-38A2184E-AE05-499C-B27B-FB5095919C08Q38211644-C1D96F9F-4B4B-4D43-BC16-9BFB60E4629FQ38270707-69B9E085-72FF-40E2-BC42-E6757DB06F66Q38686620-2E6F8F73-3440-4A36-9D3B-1C8CA5C89F2FQ38821330-301638D2-428D-4C61-A420-E31D073E60F6Q39150219-EB75E73B-B7F4-4DD4-B1A2-CDA23E26ABCDQ40652629-4C000F31-C088-4342-8E7C-3D6DAFA96A50Q41906936-A61C3ED2-0056-416C-8EAA-68F573A91F5DQ41988674-E98AAE5A-7B1F-45A4-A188-D286679D3ED5Q41990761-086BE115-7A60-4FD4-B5BA-B8C2B4305453Q42704143-9E84E758-2FCB-4788-8FD1-1E273D250C4CQ42750768-C1C0F73E-45D1-4738-9D63-1B0B7407E645Q50245151-819EA5A8-E4D7-4729-99E0-A0841B8B3D86Q51700037-2D13993E-BAC4-4907-9647-0C0D97C37DECQ52325882-99DEF77F-3F36-420D-9F98-F15EE8A2C4D7
P2860
Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contribution of oxygen-limitin ...... ion of Pseudomonas aeruginosa.
@en
Contribution of oxygen-limitin ...... ion of Pseudomonas aeruginosa.
@nl
type
label
Contribution of oxygen-limitin ...... ion of Pseudomonas aeruginosa.
@en
Contribution of oxygen-limitin ...... ion of Pseudomonas aeruginosa.
@nl
prefLabel
Contribution of oxygen-limitin ...... ion of Pseudomonas aeruginosa.
@en
Contribution of oxygen-limitin ...... ion of Pseudomonas aeruginosa.
@nl
P2860
P356
P1433
P1476
Contribution of oxygen-limitin ...... ion of Pseudomonas aeruginosa.
@en
P2093
Max Schobert
Petra Tielen
P2860
P304
P356
10.2217/FMB.10.16
P577
2010-04-01T00:00:00Z